Cyclin E2
Top View
- Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: Current Status, Resistance, and Combination Strategies Ying Niu1, Junnan Xu1,2 and Tao Sun1,
- The Role of Cyclin E in Pkc Iota-Driven Early Ovarian Tumorigenesis
- The Steroid Receptor Coactivator-3 Is Required for the Development of Castration- Resistant Prostate Cancer Jean Ching-Yi Tien1
- Kinase-Independent Function of E-Type Cyclins in Liver Cancer
- TARGETING WEE1 in STANDARD THERAPY RESISTANT ESTROGEN RECEPTOR POSITIVE BREAST CANCER a Dissertation Submitted to the Faculty Of
- ATF3, an HTLV-1 Bzip Factor Binding Protein, Promotes Proliferation of Adult T-Cell Leukemia Cells Hagiya Et Al
- REVIEW Regulation of the G1 Phase of the Mammalian Cell Cycle
- Cyclin E1 Is a Common Target of BMI1 and MYCN and a Prognostic Marker for Neuroblastoma Progression
- The Molecular Balancing Act of P16 in Cancer and Aging
- Realtime Ready Plate Layout Human Cell Cycle Regulation Panel, 96
- Journal Pre-Proof
- Cyclin-Dependent Protein Kinase Inhibitors Including Palbociclib As
- Cyclin E1 and Cyclin E2 in ER+ Breast Cancer: Prospects As Biomarkers and Therapeutic Targets
- Cyclin E1 and Cyclin E2 in ER+ Breast Cancer: Prospects As Biomarkers and Therapeutic Targets
- Role of EZH2 in the Growth of Prostate Cancer Stem Cells Isolated from Lncap Cells
- CCNE1 Amplification As a Predictive Biomarker of Chemotherapy
- Grade-Dependent Effects on Cell Cycle Progression and Apoptosis in Response to Doxorubicin in Human Bladder Cancer Cell Lines
- Cyclin E2 Is the Predominant E-Cyclin Associated with NPAT in Breast Cancer Cells Rogers Et Al